Phone: (650) 368 6983 info@airmid.com

July 2009 AIRMID partners with Kineta to develop ShK peptides February 2009 Adam Bristol joins AIRMID Board of Directors more...   Airmid Incorporated George Miljanich PhD, CEO 600 Castle Hill Road Redwood City, CA 94061 gmiljanich@comcast.net 650-368-6983 650-269-7078   AIRMID is seeking a committed development partner for its promising autoimmune products: Oral or topical psoriasis drug Oral multiple sclerosis drug

Home | Autoimmune disease | Multiple sclerosis | Type 1 diabetes mellitus | Kv1.3 Potassium Channel | PAP-1 | ShK Effector memory T cells | Contact | Sitemap Copyrights © 2007, www.airmid.com